Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07852884) titled 'First-Line Systemic Therapies in Advanced Renal Cell Carcinoma in Spain' on Sept. 24.

Study Type: Observational

Primary Sponsor: Bristol-Myers Squibb

Condition: Renal Cell Carcinoma (RCC)

Intervention: Drug: First-line systemic regimens

Recruitment Status: Not recruiting

Date of First Enrollment: July 15, 2026

Target Sample Size: 1200

Countries of Recruitment: Spain

To know more, visit https://clinicaltrials.gov/study/NCT07852884

Published by HT Digital Content Services with permission from Health Daily Digest....